Market Place
Sourcing Support
Bavarian Nordic Seeks EMA Approval To Expand Smallpox Vaccine
27 Mar 2026 //
GLOBENEWSWIRE
Bavarian Nordic Secures $22.5M Contract For Mpox And Smallpox
18 Feb 2026 //
GLOBENEWSWIRE
Bavarian Nordic Unveils 2025 Financials, Offers 2026 Outlook
12 Feb 2026 //
GLOBENEWSWIRE
Bavarian Nordic: Transactions in Share Buy-Back Program
02 Feb 2026 //
GLOBENEWSWIRE
Bavarian Nordic Initiates Share Buy-Back Program
26 Jan 2026 //
GLOBENEWSWIRE
Bavarian Nordic Expands Chikungunya Vaccine Access In Brazil
23 Jan 2026 //
GLOBENEWSWIRE
Bavarian Nordic Reports Interim Results For First 9 Months 2025
14 Nov 2025 //
GLOBENEWSWIRE
Bavarian Nordic Announces Changes To The Board Of Directors
13 Nov 2025 //
GLOBENEWSWIRE
Bavarian Provides Clarification on HERA Framework Agreement
01 Nov 2025 //
GLOBENEWSWIRE
Bavarian Nordic Win EU Deal to Boost Smallpox & Mpox Preparedness
31 Oct 2025 //
GLOBENEWSWIRE
Bavarian Nordic Notified Of Significant Stake By Morgan Stanley
29 Oct 2025 //
GLOBENEWSWIRE
Bavarian Nordic Donates More Vaccines to Support Mpox Outbreak
28 Oct 2025 //
GLOBENEWSWIRE
Bavarian Nordic Reports Positive Data For Mpox/Smallpox Vaccine
07 Oct 2025 //
GLOBENEWSWIRE
Bavarian Nordic Introduces Vimkunya in Uk for Chikungunya
06 Sep 2025 //
PHARMIWEB
Bavarian Nordic Board Addresses Takeover Offer by Nordic
26 Aug 2025 //
GLOBENEWSWIRE
Canada Accepts Bavarian Nordic`s Chikungunya Vaccine for Review
22 Jul 2025 //
GLOBENEWSWIRE
Bavarian Nordic Signs Smallpox/Mpox Vaccine Contract with Europe
09 Jul 2025 //
GLOBENEWSWIRE
Bavarian Nordic Starts Clinical Trials of Mpox Vaccine in Infants
26 Jun 2025 //
GLOBENEWSWIRE
Bavarian Nordic Sells Priority Review Voucher for USD 160 Million
18 Jun 2025 //
GLOBENEWSWIRE
Bavarian Nordic Initiates Ph 3 of Chikungunya Vaccine in Children
14 Jun 2025 //
GLOBENEWSWIRE
Bavarian Nordic share transactions by managers and affiliates
09 May 2025 //
GLOBENEWSWIRE
Bavarian Nordic gets U.S. contract for smallpox/Mpox vaccines.
06 May 2025 //
GLOBENEWSWIRE
Bavarian Nordic Gets Approval for Chikungunya Vaccine in UK
05 May 2025 //
GLOBENEWSWIRE
CDC Panel Recommends Bavarian’s Chikungunya Vaccine
16 Apr 2025 //
GLOBENEWSWIRE
Bavarian Nordic A/S Annual General Meeting 2025 Resolutions
09 Apr 2025 //
GLOBENEWSWIRE
US FDA approves freeze-dried version of Bavarian Nordic vaccine
01 Apr 2025 //
REUTERS
Bavarian Nordic A/S – Notice Convening Annual General Meeting
12 Mar 2025 //
GLOBENEWSWIRE
Bavarian Nordic’s Chikungunya Vaccine MAA Accepted In UK
07 Mar 2025 //
GLOBENEWSWIRE
Bavarian Nordic Publishes Annual Report 2024
05 Mar 2025 //
GLOBENEWSWIRE
Bavarian Nordic Reports Share Transactions By Key Managers
05 Mar 2025 //
GLOBENEWSWIRE
Bavarian Nordic Wins EU Approval For Chikungunya Vaccine
28 Feb 2025 //
GLOBENEWSWIRE
Bavarian Nordic & Biological E Partner To Chikungunya Vaccine
25 Feb 2025 //
GLOBENEWSWIRE
Bavarian Nordic Receives FDA Approval of Chikungunya Vaccine
15 Feb 2025 //
GLOBENEWSWIRE
Bavarian Nordic Reports Preliminary 2024 Financial Results & Guidance
03 Feb 2025 //
GLOBENEWSWIRE
Bavarian Receives Positive CHMP Opinion for Chikungunya Vaccine
31 Jan 2025 //
GLOBENEWSWIRE
Bavarian Nordic Completion of Share Buy-Back Program
31 Jan 2025 //
GLOBENEWSWIRE
Bavarian Transactions in Connection with Share Buy-Back Program
27 Jan 2025 //
GLOBENEWSWIRE
Bavarian Nordic Updates On Share Buy-Back Program Transactions
20 Jan 2025 //
GLOBENEWSWIRE
Bavarian Nordic Launches DKK 150M Share Buy-Back Program
09 Jan 2025 //
GLOBENEWSWIRE
AHF Urges Bavarian Nordic to Prioritize Mpox Vaccine for Africa
18 Dec 2024 //
BUSINESSWIRE
Bavarian inks mpox vaccine pact with major vaccine player
17 Dec 2024 //
FIERCE PHARMA
Bavarian Nordic Reports Share Transactions By Managers
13 Dec 2024 //
GLOBENEWSWIRE
Bavarian Nordic Establishes Incentive Program for Execs & Employees
12 Dec 2024 //
GLOBENEWSWIRE
Bavarian Nordic to shut down San Diego R&D site, lay off 48
12 Dec 2024 //
FIERCE BIOTECH
Bavarian Nordic to shut down San Diego R&D site, lay off 48
11 Dec 2024 //
FIERCE BIOTECH
Capital Increase In Bavarian Nordic Due To Employee Warrant
29 Nov 2024 //
GLOBENEWSWIRE
Report Of Transactions Of Shares By Bavarian Nordic’s Management
29 Nov 2024 //
GLOBENEWSWIRE
Bavarian Nordic Secures $340M Orders for Mpox Vaccine in 2025
15 Nov 2024 //
REUTERS
US Expected to Increase Biodefense Spending under Trump
15 Nov 2024 //
REUTERS
First Children Vaccinated in Study for Nordic’s Mpox Vaccine
29 Oct 2024 //
GLOBENEWSWIRE
NIH study shows mpox shot elicits immune response in teens
17 Oct 2024 //
FIERCE PHARMA
WHO approves Bavarian Nordic`s mpox vaccine for adolescents
11 Oct 2024 //
REUTERS
Bavarian Nordic Signs Agreement With UNICEF For Mpox Vaccines
26 Sep 2024 //
GLOBENEWSWIRE
Bavarian Nordic Upgrades its Financial Guidance for 2024
26 Sep 2024 //
GLOBENEWSWIRE
Bavarian Nordic Gets USD 63M for Smallpox/Mpox Vaccine
24 Sep 2024 //
GLOBENEWSWIRE
Bavarian says mpox vaccine approved by EU regulator for adolescents
20 Sep 2024 //
REUTERS
Bavarian Nordic Receives EMA Approval Of Mpox Vaccine
19 Sep 2024 //
GLOBENEWSWIRE
UK government buys over 150,000 doses of Bavarian Nordic`s mpox vaccine
17 Sep 2024 //
REUTERS
Canada`s Only Single-Dose Cholera Vaccine Available Nationwide
16 Sep 2024 //
GLOBENEWSWIRE
WHO clears Bavarian Nordic`s vaccine for mpox, sets up access scheme
14 Sep 2024 //
REUTERS
